The litigation against manufacturers of pelvic mesh devices continues to increase nationwide. A pelvic mesh implant is a synthetic material implanted and tied to ligaments or bone to lift and support internal organs. The implants were introduced over a decade ago, and can serve as an alternative to a hysterectomy. Thousands of women, who were allegedly uninformed about the dangers involved with the mesh implants, have since complained of injuries, including severe pain, infections and bleeding that often require follow-up surgeries.
As we have previously reported, C.R. Bard, manufacturer of the Avaulta pelvic mesh device, was believed to know of the risks associated with its device before it hit the market. There are approximately 12,500 lawsuits pending against C.R. Bard for the Avaulta device. The majority of these cases are consolidated as part of a federal multidistrict litigation (MDL) before U.S. District Judge Joseph Goodwin in the Southern District of West Virginia.
C.R. Bard has agreed to settle 500 of the pending cases for an undisclosed amount. The manufacturer has reported that it will continue to engage in settlement discussion with the remaining plaintiffs.
If you or a loved one has experienced any injury from the use of a vaginal mesh implant, please contact Stark & Stark and speak to one of the Mass Tort attorneys, free of charge, who can help assess any claims that you might have against a manufacturer of the vaginal mesh device.